Neuromyelitis optica News and Research

RSS
FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

UT Southwestern scientists identify gene mutation linked with perplexing brain condition

UT Southwestern scientists identify gene mutation linked with perplexing brain condition

Popular allergy drug may reduce relapses in patients with neuromyelitis optica

Popular allergy drug may reduce relapses in patients with neuromyelitis optica

Study: Most patients with unknown spinal cord inflammation have alternative, specific diagnosis

Study: Most patients with unknown spinal cord inflammation have alternative, specific diagnosis

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

Unique microscope reveals clues to destructive autoimmune disease

Unique microscope reveals clues to destructive autoimmune disease

Study highlights possible reasons for MS misdiagnosis

Study highlights possible reasons for MS misdiagnosis

Rare DNA  alteration may increase rsk of multiple sclerosis

Rare DNA alteration may increase rsk of multiple sclerosis

Medical professionals compare different treatment methods for Neuromyelitis optica

Medical professionals compare different treatment methods for Neuromyelitis optica

Medical professionals compare different treatment options for Neuromyelitis optica

Medical professionals compare different treatment options for Neuromyelitis optica

Escalation therapy for neuromyelitis attacks improves remission rates

Escalation therapy for neuromyelitis attacks improves remission rates

Cryoport to support future clinical trials for Opexa's personalized T-cell immunotherapy programs for MS, NMO

Cryoport to support future clinical trials for Opexa's personalized T-cell immunotherapy programs for MS, NMO

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

Quadrivalent HPV vaccine cleared of multiple sclerosis risk

Quadrivalent HPV vaccine cleared of multiple sclerosis risk

OMRF scientist selected to receive EMD Serono's Grant for Multiple Sclerosis Innovation

OMRF scientist selected to receive EMD Serono's Grant for Multiple Sclerosis Innovation

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

Research findings may lead to new treatments, approaches for controlling multiple sclerosis